Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes

(2019) Gloria Dalla Costa et al.   NEUROLOGY

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Epidemiology and treatment of multiple sclerosis in elderly populations

(2019) Caila B. Vaughn et al.   Nature Reviews Neurology

Deep gray matter volume loss drives disability worsening in multiple sclerosis

(2018) Arman Eshaghi et al.   ANNALS OF NEUROLOGY

Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease

(2018) Christina J. Azevedo et al.   ANNALS OF NEUROLOGY

Progression of regional grey matter atrophy in multiple sclerosis

(2018) Arman Eshaghi et al.   BRAIN

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis

(2018) Michael G. Dwyer et al.   JOURNAL OF NEUROIMAGING

Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality

(2018) Ferdinand Schweser et al.   NEUROIMAGE

Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis

(2018) Robert Zivadinov et al.   RADIOLOGY

Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study

(2018) D. Jakimovski et al.   EUROPEAN JOURNAL OF NEUROLOGY

Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage

(2018) Dejan Jakimovski et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis

(2018) Tanuja Chitnis et al.   Annals of Clinical and Translational Neurology

The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain

(2016) Lukas Haider et al.   BRAIN

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

(2016) Jens Kuhle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis

(2016) Niels Bergsland et al.   JOURNAL OF NEUROIMAGING

Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study

(2016) Robert Zivadinov et al.   Multiple Sclerosis Journal

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study

(2016) Robert Zivadinov et al.   Multiple Sclerosis Journal

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant

(2015) Martijn D. Steenwijk et al.   BRAIN

Pathological mechanisms in progressive multiple sclerosis

(2015) Don H Mahad et al.   LANCET NEUROLOGY

Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis

(2015) Martina Absinta et al.   NEUROLOGY

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

(2014) Manuel A. Friese et al.   Nature Reviews Neurology

Iron in multiple sclerosis: roles in neurodegeneration and repair

(2014) Erin Stephenson et al.   Nature Reviews Neurology

Disease-specific molecular events in cortical multiple sclerosis lesions

(2013) Marie Therese Fischer et al.   BRAIN

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model

(2013) Michael G. Dwyer et al.   NEUROIMAGE

Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis

(2013) Robert Zivadinov et al.   RADIOLOGY

A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology

(2012) James Kolasinski et al.   BRAIN

Measurement and clinical effect of grey matter pathology in multiple sclerosis

(2012) Jeroen JG Geurts et al.   LANCET NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis

(2011) Rose Gelineau-Morel et al.   HUMAN BRAIN MAPPING

Risk factors for and management of cognitive dysfunction in multiple sclerosis

(2011) Ralph H. B. Benedict et al.   Nature Reviews Neurology

A Bayesian model of shape and appearance for subcortical brain segmentation

(2011) Brian Patenaude et al.   NEUROIMAGE

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis

(2011) Robert Zivadinov et al.   NEUROIMAGE

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis

(2010) Roberta Magliozzi et al.   ANNALS OF NEUROLOGY

Gray matter atrophy in multiple sclerosis: A longitudinal study

(2008) Elizabeth Fisher et al.   ANNALS OF NEUROLOGY